NexImmune, Inc. (NEXI)
OTCMKTS · Delayed Price · Currency is USD
1.010
+1.010 (1,009.00%)
Sep 12, 2025, 3:28 PM EDT
NexImmune Market Cap
NexImmune has a market cap or net worth of $13.95 thousand as of September 16, 2025. Its market cap has decreased by -99.91% in one year.
Market Cap
13.95K
Enterprise Value
-2.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.01
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 13.95K, a decrease of -100.00%. That is a compound annual growth rate of -90.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 13.95K | -91.31% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
| Feb 12, 2021 | 545.88M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |